These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11770728)

  • 1. Recent advances in the treatment of autoimmune bullous diseases.
    Takamori K
    J Dermatol; 2001 Nov; 28(11):654-7. PubMed ID: 11770728
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating immunobullous diseases: an update.
    Reynaert S; Black MM
    Dermatol Nurs; 2004 Feb; 16(1):29-34, 70. PubMed ID: 15022502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Practical management of the most common autoimmune bullous diseases].
    Suárez-Fernández R; España-Alonso A; Herrero-González JE; Mascaró-Galy JM
    Actas Dermosifiliogr; 2008; 99(6):441-55. PubMed ID: 18558052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study.
    Garssen MP; van Koningsveld R; van Doorn PA; Merkies IS; Scheltens-de Boer M; van Leusden JA; van Schaik IN; Linssen WH; Visscher F; Boon AM; Faber CG; Meulstee J; Prick MJ; van den Berg LH; Franssen H; Hiel JA; van den Bergh PY; Sindic CJ
    J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):1012-3. PubMed ID: 17702789
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined immunosuppressive therapy of autoimmune bullous dermatoses].
    Grando SA
    Sov Med; 1988; (2):113-5. PubMed ID: 3291136
    [No Abstract]   [Full Text] [Related]  

  • 6. Bullous pemphigoid treatment review.
    Patton T; Korman NJ
    Expert Opin Pharmacother; 2006 Dec; 7(17):2403-11. PubMed ID: 17109614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous Pemphigoid Successfully Treated With a Combination Therapy of Plasmapheresis Followed by Intravenous High Dose Immunoglobulin.
    Hattori Y; Takahashi T; Seishima M
    Ther Apher Dial; 2017 Aug; 21(4):421-423. PubMed ID: 28378368
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive therapy for autoimmune bullous diseases.
    Meurer M
    Clin Dermatol; 2012; 30(1):78-83. PubMed ID: 22137230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy of bullous pemphigoid with mycophenolate mofetil: old drug, new use.
    Ratnam KV
    Singapore Med J; 2001 Oct; 42(10):482-4. PubMed ID: 11874153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune bullous diseases: diagnosis and management.
    McCuin JB; Hanlon T; Mutasim DF
    Dermatol Nurs; 2006 Feb; 18(1):20-5. PubMed ID: 16550892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction treatment by combining immunoglobulins, plasmapheresis and rituximab in hypersensitive patients receiving cadaveric renal allograft].
    Rufino Hernández JM; Cabello Moya E; González-Posada JM; Hernández Marrero D; Pérez Tamajón L; Marrero Miranda D; García Rebollo S; Martín Urcuyo B; Rodríguez Hernández A; Franco Maside A; Barrios del Pino Y; Rodríguez Rodríguez R; Maceira Cruz B; Torres Ramírez A; Salido Ruiz E
    Nefrologia; 2010; 30(2):252-7. PubMed ID: 20098463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Double filtration plasmapheresis is effective in the treatment of 3 cases of autoimmune bullous disease].
    Yamada H; Nakajima S; Yaguchi H; Takamori K; Ogawa H
    Nihon Hifuka Gakkai Zasshi; 1988 Mar; 98(3):361-6. PubMed ID: 3045376
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of autoimmune blistering diseases.
    Levy M; Rico MJ
    Dermatol Clin; 1999 Apr; 17(2):431-40, x. PubMed ID: 10327307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of autoimmune bullous diseases: pharmacology and therapeutics.
    Mutasim DF
    J Am Acad Dermatol; 2004 Dec; 51(6):859-77; quiz 878-80. PubMed ID: 15583576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of steroid refractory inflammatory bowel disease (IBD) with mycophenolate mofetil (MMF).
    Florin TH; Roberts RK; Watson MR; Radford-Smith GL
    Aust N Z J Med; 1998 Jun; 28(3):344-5. PubMed ID: 9673748
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bullous pemphigoid: diagnostics and new therapeutic strategies].
    Hofmann SC; Bruckner-Tuderman L
    Dtsch Med Wochenschr; 2006 Feb; 131(8):389-92. PubMed ID: 16479471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear IgA bullous dermatosis responsive to trimethoprim-sulfamethoxazole.
    Peterson JD; Chan LS
    Clin Exp Dermatol; 2007 Nov; 32(6):756-8. PubMed ID: 17868394
    [No Abstract]   [Full Text] [Related]  

  • 18. Figurate erythema: an unusual presentation of the nonbullous phase of bullous pemphigoid.
    Mussani F; Siddha S; Rosen CF
    J Cutan Med Surg; 2012; 16(1):61-3. PubMed ID: 22417998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodies.
    Czernik A; Bystryn JC
    Arch Dermatol; 2008 May; 144(5):658-61. PubMed ID: 18490594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of patients with autoimmune bullous disorders in Germany.
    Schmidt E; Zillikens D
    Dermatol Clin; 2011 Oct; 29(4):663-71. PubMed ID: 21925015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.